Show items per page
Elements: 106
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study Weber, R.; Huber, M.; Rickenbach, M.; Furrer, Hansjakob; ... Ledergerber, Bruno 2009
add to browser selection
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study Rauch, Andri; Rickenbach, Martin; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2005
add to browser selection
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study Drescher, Sara M; von Wyl, Viktor; Yang, Wan-Lin; Böni, Jürg; ... Calmy, Alexandra 2014
add to browser selection
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008 Elzi, Luigia; Marzolini, Catia; Furrer, Hansjakob; Ledergerber, Bruno; ... Battegay, Manuel 2010
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study Yerly Ferrillo, Sabine; Kaiser, Laurent; Perneger, T. V.; Cone, R. W.; ... Perrin, Luc 2000
add to browser selection
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study Felley, Christian; Morris, Michael Andréw; Wonkam, Ambroise; Hirschel, Bernard; ... Frossard, Jean-Louis 2004
add to browser selection
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study Wang, Qing; Young, Jim; Bernasconi, Enos; Cavassini, Matthias; ... Martinez De Tejada Weber, Begona 2013
add to browser selection
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients Beerenwinkel, Niko; Montazeri, Hesam; Schuhmacher, Heike; Knupfer, Patrick; ... Calmy, Alexandra 2013
add to browser selection
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients Bibert, Stéphanie; Wojtowicz, Agnieszka; Taffe, Patrick; Manuel, Oriol; ... Bochud, Pierre-Yves 2014
add to browser selection
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study Fux, C. A.; Rauch, Andri; Simcock, Mathew; Bucher, H. C.; ... Furrer, Hansjakob 2008
add to browser selection
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study Fux, C. A.; Simcock, Mathew; Wolbers, Marcel; Bucher, H. C.; ... Furrer, Hansjakob 2007
add to browser selection
Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country Stucki, David; Ballif, Marie; Egger, Matthias; Furrer, Hansjakob; ... Fenner, Lukas 2016
add to browser selection
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study Young, Jim; De Geest, Sabina; Spirig, Rebecca; Flepp, Markus; ... Bucher, H. C. 2004
add to browser selection
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients Glass, T. R.; De Geest, Sabina; Hirschel, Bernard; Battegay, Manuel; ... Bucher, H. C. 2008
add to browser selection
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study Conen, Anna; Fehr, Jan; Glass, T. R.; Furrer, Hansjakob; ... Battegay, Manuel 2009
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir Young, Jim; Schäfer, Juliane; Fux, Christoph A; Furrer, Hansjakob; ... Bucher, Heiner C 2012
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared Keiser, Olivia; Orrell, Catherine; Egger, Mathias; Wood, Robin; ... Boulle, A. 2008
add to browser selection
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study Wolf, Katja; Young, James; Rickenbach, Martin; Vernazza, Pietro; ... Bucher, H. C. 2003
add to browser selection
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study Glass, T. R.; Ungsedhapand, C.; Wolbers, M.; Weber, R.; ... Bucher, H. C. 2006
add to browser selection
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study Marzolini, Catia; Elzi, Luigia; Gibbons, Sara; Weber, Rainer; ... Battegay, Manuel 2010
add to browser selection
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Fellay, Jacques; Boubaker, K.; Ledergerber, Bruno; Bernasconi, Enos; ... Telenti, A. 2001
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals Lubomirov, Rubin; Arab, Mona; Rotger, Margalida; Fayet-Mello, Aurélie; ... Telenti, Amalio 2013
add to browser selection
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection Metzner, Karin J; Scherrer, Alexandra U; Preiswerk, Benjamin; Joos, Beda; ... Günthard, Huldrych F 2013
add to browser selection
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy Polesel, Jerry; Clifford, Gary M.; Rickenbach, Martin; Dal Maso, Luigino; ... Franceschi, Silvia 2008
add to browser selection
Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: role of immigration and HIV infection Fenner, Lukas; Gagneux, Sebastien; Helbling, Peter; Battegay, Manuel; ... Egger, Matthias 2012
add to browser selection
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population Jaggy, Christian; von Overbeck, Jan; Ledergerber, Bruno; Schwarz, Claude; ... Hirschel, Bernard 2003
add to browser selection
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland Kouyos, R. D.; von Wyl, Viktor; Yerly Ferrillo, Sabine; Boni, Jurg; ... Gunthard, Huldrych 2010
add to browser selection
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders Tarr, P. E.; Taffe, Patrick; Bleiber, Gabriela; Furrer, Hansjakob; ... Telenti, Amalio 2005
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
add to browser selection
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival Staehelin, Cornelia; Rickenbach, Martin; Low, Nicola; Egger, Martin; ... Furrer, Hansjakob 2003
add to browser selection
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine Sudre, Philippe; Chave, J. P.; Ruef, Christian; Iten, A.; ... Hirschel, Bernard 1997
add to browser selection
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study Glass, Tracy R.; Battegay, Manuel; Cavassini, Matthias; De Geest, Sabina; ... Bucher, Heiner C. 2010
add to browser selection
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study Staehelin, Cornelia; Keiser, Olivia; Calmy, Alexandra; Weber, Rainer; ... Furrer, Hansjakob 2012
add to browser selection
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection Kaufmann, G. R.; Khanna, Nina; Weber, Rainer; Perrin, Luc; ... Battegay, Manuel 2004
add to browser selection
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland von Wyl, Viktor; Yerly Ferrillo, Sabine; Burgisser, Philippe; Klimkait, Thomas; ... Swiss, H. I. V. Cohort Stud 2009
add to browser selection
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study Young, Jim; Weber, Rainer; Rickenbach, Martin; Furrer, Hansjakob; ... Bucher, H. C. 2005
add to browser selection
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients Metzner, Karin J; Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2014
add to browser selection
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population Gueler, Aysel; Moser, André; Calmy, Alexandra; Günthard, Huldrych F; ... Egger, Matthias 2017
add to browser selection
Late presentation of HIV-infected individuals Battegay, Manuel; Fluckiger, Ursula; Hirschel, Bernard; Furrer, Hansjakob 2007
add to browser selection
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy Greub, Gilbert; Cozzi-Lepri, Alessandro; Ledergerber, Bruno; Staszewski, Schlomo; ... Telenti, Amalio 2002
add to browser selection
Infrequent transmission of HIV-1 drug-resistant variants Yerly Ferrillo, Sabine; Jost, Stéphanie; Telenti, Amalio; Flepp, Markus; ... Perrin, Luc 2004
add to browser selection
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations von Wyl, Viktor; Yerly Ferrillo, Sabine; Böni, Jürg; Shah, Cyril; ... Günthard, Huldrych F 2012
add to browser selection
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych 2010
add to browser selection
Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals Rotger, Margalida; Gsponer, Thomas; Martinez, Raquel; Taffe, Patrick; ... Tarr, Philip E. 2010
<< previous | 1 | 2 | 3 |